Research plays an important role in establishing evidence-based practice and providing objective data to guide clinical care and self-care for patients with lymphedema. However, not at all research is created equal. There are various components of the research study to consider to determine if the study was well designed. Depending on these factors, the results and conclusions may be very strong or suggest that further research is needed.
Dr. Mackenzi Pergolotti is the Director of Research for ReVital Cancer Rehabilitation, adjunct professor at Colorado State University and at the University of North Carolina at Chapel Hill, and she will help us understand research in this webinar intended for lymphedema therapists.
As an occupational therapist, Dr. Pergolotti worked at the Memorial Sloan Kettering Cancer Center (MSK) developing programs aimed to better address the needs of multiple populations. Realizing the impact of cancer rehabilitation provided at centers like MSK, she was driven to build the evidence-base and increase access to cancer rehabilitation programs nation-wide.
Dr. Pergolotti was trained the University of North Carolina at Chapel Hill where she worked collaboratively with researchers from the Cecil G. Sheps Center for Health Services Research, the Gillings School of Global Public Health, in the Department of Health Policy and Management, the Cancer Research Outcomes Group and the Geriatric Oncology Program at the Lineberger Comprehensive Cancer Center through pre-doctoral and post-doctoral fellowships to look at utilization, access to and the quality of cancer rehabilitation. Dr. Pergolotti’s Pre-Doctoral fellowship was supported by a T32 National Research Service Award (NRSA) Institutional Training Grant from the Agency for Healthcare Research and Quality (AHRQ), and her Post-Doctoral fellowships were funded through an R25 Cancer Care Quality Training Program from the National Cancer Institute. Dr. Pergolotti has published over 25 peer-reviewed manuscripts about cancer rehabilitation and presented at both National and International conferences. Last year, Pergolotti was a finalist for a competitive Nursing and Allied Health Award within the International Society for Geriatric Oncology; was selected to participate in NCI-funded Building, Implementing and Evaluating supportive care programstraining, and was selected for the Colorado Clinical and Translational Science Institute Immersion Training in Community Engagementproject.
After being on faculty for two years at Colorado State University, Department of Occupational Therapy, Dr. Pergolotti decided to shift from a faculty role to work full time towards her dream of realizing quality, multidisciplinary cancer care for survivors and joined the ReVital team. She was recently interviewed by the American Society for Clinical Oncology Post News, for their special section, Women in Oncology, titled: A Leader in the Emerging Field of Occupational Therapy in Oncology.
Registration info will be available shortly.
NLN members - $10
General public - $125
We look forward to you joining us on Wednesday, December 12, 2018 at 1:00 pm ET.